Published in Pacing Clin Electrophysiol on March 01, 1993
Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period. Heart (1997) 0.81
Long-term follow up of patients with implantable cardioverter-defibrillators and mild, moderate, or severe impairment of left ventricular function. Heart (1997) 0.77
Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience. Chest (2001) 5.12
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med (2000) 4.04
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. Eur Heart J (2004) 1.66
Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol (1992) 1.66
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart (2006) 1.53
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart (1997) 1.42
Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence: a prospective, multicentre study. Europace (1999) 1.41
[Diagnostic contribution of magnetic resonance in clinically suspected arrhythmogenic dysplasia of the right ventricle]. G Ital Cardiol (1996) 1.39
Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes. J Med Genet (2003) 1.13
Nightmares and sleep disturbances with simvastatin and metoprolol. Ann Pharmacother (2001) 1.12
A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol (1994) 1.09
Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J (2001) 1.09
Laminopathies: many diseases, one gene. Report of the first Italian Meeting Course on Laminopathies. Acta Myol (2011) 1.01
Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation (1995) 0.99
Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol (1994) 0.99
Atrial premature beats coupling interval determines lone paroxysmal atrial fibrillation onset. Int J Cardiol (1992) 0.97
Impact of consistent atrial pacing algorithm on premature atrial complexe number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: a randomized prospective cross over study. J Interv Card Electrophysiol (2001) 0.91
[Paroxysmal atrial fibrillation: study of the pattern of onset using dynamic electrocardiography]. Cardiologia (1989) 0.89
Paroxysmal atrial fibrillation in sleep. Sleep (1997) 0.85
Evaluation by cardiopulmonary exercise test of DDDR versus DDD pacing. Pacing Clin Electrophysiol (1992) 0.84
Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters. Heart (2002) 0.83
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. Heart (1999) 0.82
Tocainide and metoprolol: an efficacious therapeutic combination in the treatment of premature ventricular beats. Clin Cardiol (1989) 0.79
Usefulness of nicorandil in congestive heart failure. Am J Cardiol (1990) 0.78
[Cerebral and renal aspergillosis in a patient with orthotopic heart transplant: diagnosis, treatment and follow-up]. Cardiologia (1989) 0.77
Winning the war, far, in developing countries. Novel anticoagulants as a new weapon against stroke. Int J Cardiol (2011) 0.76
Prolonged QRS and QTc interval and mortality. Heart (2008) 0.75
Intravenous administration of propafenone. J Am Coll Cardiol (1992) 0.75
Peri-operative management of patients taking antithrombotic therapy: need for an integrated proactive approach. Int J Clin Pract (2011) 0.75
[Pseudoischemic T waves: a possible electrophysiologic mechanism]. Cardiologia (1990) 0.75
Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens. Int J Cardiol (1997) 0.75
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. Scand J Med Sci Sports (2010) 0.75
Sick sinus syndrome and diffuse impairment of the conduction system in a child: successful pacing with a steroid eluting endocardial pacing lead. Pediatr Cardiol (1992) 0.75
Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal. Drug Saf (1995) 0.75
[Role of electrophysiologic study in the sick sinus syndrome and in carotid sinus syndrome]. Minerva Cardioangiol (1988) 0.75
[Refractory sustained ventricular tachycardia. Electrocardiographic characterization and prognosis]. Recenti Prog Med (1988) 0.75
[Paroxysmal atrial fibrillation: the significance of the dynamic behavior of the atrial cycle]. Cardiologia (1993) 0.75
[Electrocardiographic, clinical and prognostic evaluation of sustained ventricular tachycardia in acute and chronic ischemic heart disease]. Minerva Cardioangiol (1989) 0.75
[Hyperkinetic ventricular arrhythmia during the treadmill test in chronic ischemic heart disease]. Minerva Cardioangiol (1990) 0.75
[Non-invasive diagnosis of acute rejection in heart transplant]. Cardiologia (1989) 0.75
A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes. Int J Clin Pharmacol Res (1991) 0.75
[Propafenone: evaluation of antiarrhythmic efficacy in hyperkinetic ventricular arrhythmia using acute oral test]. Cardiologia (1988) 0.75
The cost of atrial fibrillation in Italy: a five-year analysis of healthcare expenditure in the general population. From the Italian Survey of Atrial Fibrillation Management (ISAF) study. Eur Rev Med Pharmacol Sci (2017) 0.75
Minimal effective concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapy. Cardiovasc Drugs Ther (1990) 0.75
Neurocardiogenic syncope in selected pediatric patients--natural history during long-term follow-up and effect of prophylactic pharmacological therapy. Cardiovasc Drugs Ther (2001) 0.75
[Hyperkinetic ventricular arrhythmias in acute myocardial infarction: different etiopathogenetic mechanisms?]. Minerva Cardioangiol (1987) 0.75
Role of the automatic implantable cardioverter defibrillator in the prevention of sudden cardiac death. Int J Artif Organs (1992) 0.75
[Action of x-ray on RNA in the neoblasts of Polycelis nigra during regeneration]. Radiobiol Radioter Fis Med (1967) 0.75
[Idiopathic atrial fibrillation: clinical and therapeutic problems]. Cardiologia (1991) 0.75